Please see this quick reference guide for commonly sent samples from primary care. This guide applies to all infection samples sent from primary care in BNSSG. The samples are all processed at NBT.
As part of Infection sciences commitment to improve patient care and environmental sustainability we are reducing rejected specimens. Many rejected specimens are due to incorrect specimen container. This could result in a delay in diagnosis and treatment for patients and leads to unnecessary waste and transport costs.
Please ensure samples are submitted with the following:
Viral Nose and Throat Swabs/Vesicles/Eyes/Genital lesions/M pox |
|
Any of the following tubes may be used Red top Copan tube Purple top Copan tube White top Copan tube Green top Copan |
Urine MC&S if >2mls |
|
Boric Acid container Olive Green/Red |
Urine MC&S if < 2mls ie paediatric samples |
|
White top universal containers NB if sample is >2mls this will be rejected by the laboratory |
Bordatella Pertussis Pernasal Swab for PCR/ MC&S |
|
Orange lidded minitip sigma transwabs Please UKHSA for advice of testing Pertussis: guidelines for public health management - GOV.UK (www.gov.uk) |
Bordatella Pertussis Pernasal Swab for PCR only |
|
green top swab orange and purple Please UKHSA for advice of testing Pertussis: guidelines for public health management - GOV.UK (www.gov.uk) |
Swab for bacterial/candida culture ears/eyes/wounds/ nose/ throat/ high vaginal/lower vaginal/cervical/self taken (for Chlamydia and Gonorrhoea and Trichomonas NAATS send APTIMA tube) |
|
purple top liquid swab |
Chlamydia and Gonorrhoea and( Trichomonas by special request only)NAATS swab Vaginal/Eye |
|
Aptima (use Vaginal) Swab |
Chlamydia and Gonorrhoea NAATS urine |
|
preferred sample for males please do not under/overfill SAMPLE SHOULD BE IN BETWEEN THE TWO BLACK LINES |
Stool Bacterial PCR Giardia and Cryptosporidium C difficile PCR Viral Gastroenteritis and Norovirus PCR Ova cysts and parasites (OCP) H pylori antigen |
|
blue topped with a scoop minimum ⅓ full ideally separate samples for each ICE request sticker If sending for OCP send 3 samples post dated request with different days otherwise these will be rejected by the lab |
Blood for Bacterial/Viral Serology eg Lyme/CMV/EBV/Hepatitis/HIV/Varicella Zoster/ Measles |
|
Gold top |
Blood for viral PCR eg CMV/EBV/ HIV Viral load, Hepatitis B, C |
|
Purple EDTA tube |
Mumps (oral fluid IgM PCR) Acute cases only. For immunity testing please see Viral Serology above |
|
ALL suspected MUMPS CASES SHOULD BE DISCUSSED with UKHSA PRIOR TO TESTING Oral fluid testing -please contact UKHSA to request a kit 0300 3038162 If wanting to test in clinic please discuss with Virology (after discussing with UKHSA) at Severn infection sciences to avoid delay |
Measles
|
|
ALL SUSPECTED MEASLES CASES SHOULD BE DISCUSSED WITH UKHSA PRIOR TO TESTING Oral fluid testing-please contact UKHSA to request a kit 0300 3038162 If wanting to test in clinic please discuss first with UKHSA to risk assess |
MRSA screen swab
|
|
purple top sigma trans swab If needing to screen urine send boric acid container |
Sputum MC&S |
|
universal white top container |
Threadworm/Enterobius Kit |
|
Send if diagnostic uncertainty or treatment resistant cases to confirm diagnosis. Kit can be requested from pathology see above |
Fungal skin/nail scraping for microscopy and culture |
|
Mycology collection kit |
To request testing kits and tubes please contact: pathologyconsumablessouthmead@nbt.nhs.uk
For any other queries or suggestions for improvements relating to the below please email: microbiology@nbt.nhs.uk
For a full list of Pathology testing repertoire including turnaround times please see
Test Information | North Bristol NHS Trust (nbt.nhs.uk)
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.